DT
ADCT icon

Diversified Trust’s ADC Therapeutics ADCT Stock Holding History

Diversified Trust’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,115
Closed -$56.5K – 1038
2025
Q3 		$56.5K Hold
14,115
– – ﹤0.01% 976
2025
Q2 		$37.8K Hold
14,115
– – ﹤0.01% 920
2025
Q1 		$19.9K Buy
+14,115
New +$24K ﹤0.01% 910

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Diversified Trust's ADCT Position: Q4 2025 in Review

Diversified Trust sold out of ADC Therapeutics (ADCT) in Q4 2025, closing a stake of 14,115 shares — an estimated $56.5K sold.

Diversified Trust first reported a position in ADCT in Q1 2025 and held it in 3 quarters. The position peaked at $56.5K in Q3 2025. 115 funds tracked by Wall St. Rank hold ADCT as of Q4 2025.

  • Diversified Trust reported no remaining ADC Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Diversified Trust sold 14,115 ADC Therapeutics shares in Q4 2025, an estimated $56.5K.
  • Diversified Trust first reported a position in ADC Therapeutics in Q1 2025 and held it in 3 quarters.
  • Diversified Trust's ADC Therapeutics position peaked at $56.5K in Q3 2025.
  • 115 funds tracked by Wall St. Rank held ADC Therapeutics as of Q4 2025.

Based on Diversified Trust's 13F filing for Q4 2025, filed 9 Jan 2026.